Amgen Commences Strategic Collaboration With BeiGene to Expand Oncology Presence in China
Amgen announced the successful closing of the transaction to enter into a strategic collaboration with BeiGene that will significantly accelerate Amgen's plans to expand...
Lokelma approved in China for the treatment of adult patients with hyperkalaemia
AstraZeneca’s Lokelma has been approved in China for the treatment of adult patients with hyperkalaemia (elevated levels of potassium in the blood).
The approval by...
Syneos Health Insights Hub Releases 2020 Health Trends, Identifying Critical Shifts Impacting Drug Development and Commercialization
The Syneos Health® Insights Hub, a dynamic destination for what’s next thinking and future-focused insights, released 2020 Health Trends: Changing Lives and Life Sciences....
Merck Establishes Strategic Oncology Collaboration with Taiho and Astex
Merck known as MSD outside the United States and Canada, announced an exclusive worldwide research collaboration and license agreement with Taiho Pharmaceutical Co, Ltd.,...
Cergentis launches TLA technology for complete cancer gene mutation sequencing
Cergentis, a genomics company that develops and commercialises kits and services based on its proprietary Targeted Locus Amplification (TLA) technology, announced the launch of...
FedEx Express ships pharma goods for Japanese clinical trial
FedEx Express is supporting a clinical trial run by Life Science Center in Tokyo, Japan, by shipping pharma products to and from the Center...
Dicerna, Novo Nordisk sign RNAi deal for liver-related cardio-metabolic diseases
US-based Dicerna Pharmaceuticals and Novo Nordisk have signed a deal worth up to around $607m to discover and develop drugs for liver-related cardio-metabolic diseases.
In...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...